Home » Stocks » ANNX

Annexon Biosciences, Inc. (ANNX)

Stock Price: $27.45 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 1.05B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 28.47M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $27.45
Previous Close $27.45
Change ($) 0.00
Change (%) 0.00%
Day's Open 24.17
Day's Range 23.64 - 27.75
Day's Volume 138,828
52-Week Range 17.50 - 30.55

News

There are no news available yet.

About ANNX

Annexon, a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX0... [Read more...]

Industry
Biotechnology
IPO Date
Jul 24, 2020
CEO
Douglas Love J.D., Esq.
Employees
38
Stock Exchange
NASDAQ
Ticker Symbol
ANNX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for ANNX stock is "Strong Buy." The 12-month stock price forecast is 34.50, which is an increase of 25.68% from the latest price.

Price Target
$34.50
(25.68% upside)
Analyst Consensus: Strong Buy